Prasco Laboratories Announces New, Expanded Roles for Key Executives
Published: Dec 06, 2011
"I am extremely pleased to announce these management changes," said E. Thomas Arington. "As one of the founders of Prasco, Chris has played a critical role in the development and evolution of the company from day-to-day operations to the larger strategic picture," Arington said. "Mr. Vucurevich brings extensive experience in the pharmaceutical industry, as well as a 'get it done' management style and a commitment to excellence, which is so appropriate for Prasco at this point in time. As CFO, Mr. David Furniss brings financial acumen and over twenty years of pharmaceutical industry experience. Mr. Furniss, along with Mr. Chris Gilmore, a former Prasco Authorized Generics Business executive, will play key roles in developing and implementing new business opportunities, including acquisitions," Arington concluded.
"It is an honor to accept the position as Prasco CEO and to join Mr. David Vucurevich, in leading Prasco forward," said Chris Arington, CEO. "I am extremely pleased with Prasco's existing leadership team and we look forward to expanding Prasco's role in the pharmaceutical industry."
About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution. For more information, visit www.prasco.com.
SOURCE Prasco Laboratories